Abstract
Glucose tolerance and insulin secretion have been measured in six overweight non-diabetic subjects on first presentation and after 5 weeks of fenfluramine treatment without dietary restriction. There was a significant improvement in glucose tolerance and a marginally significant decrease in insulin secretion.
In another six overweight non-diabetic subjects, insulin secretion and glucose tolerance were measured on first presentation, after 10 weeks of low-calorie diet, and then after a further 10 weeks of the same low-calorie diet with the addition of fenfluramine. Diet alone did not produce any significant effect on glucose tolerance, but did bring about a significant decrease in insulin secretion. The addition of fenfluramine to the dietary therapy was associated with a marginally significant improvement in the glucose tolerance and a highly significant decrease in insulin secretion. This further decrease in insulin secretion was significantly greater than the decrease produced by diet alone in these six subjects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURNS T. W., BREGANT R., VANPEENAN H. J., HOOD T. E. EVALUATION OF THE ORAL GLUCOSE TOLERANCE TEST BY A CONTINUOUS SAMPLING TECHNIQUE. J Lab Clin Med. 1965 Jun;65:927–943. [PubMed] [Google Scholar]
- BUTTERFIELD W. J., HOLLING H. E. Peripheral glucose metabolism in fasting control subjects and diabetic patients. Clin Sci. 1959 May;18:147–174. [PubMed] [Google Scholar]
- Bagdade J. D., Bierman E. L., Porte D., Jr The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest. 1967 Oct;46(10):1549–1557. doi: 10.1172/JCI105646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dykes J. R. The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics. Postgrad Med J. 1973 May;49(571):318–324. doi: 10.1136/pgmj.49.571.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrant P. C., Neville R. W., Stewar G. A. Insulin release in response to oral glucose in obesity: the effect of reduction of body weight. Diabetologia. 1969 Jun;5(3):198–200. doi: 10.1007/BF01213681. [DOI] [PubMed] [Google Scholar]
- HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herold E., Kemper F., Opitz K. Einfluss appetithemmender Substanzen auf Kohlenhydrat- und Fettsäurestoffwechsel. Arzneimittelforschung. 1965 Jun;15(6):657–659. [PubMed] [Google Scholar]
- Kalkhoff R. K., Kim H. J., Cerletty J., Ferrou C. A. Metabolic effects of weight loss in obese subjects. Changes in plasma substrate levels, insulin and growth hormone responses. Diabetes. 1971 Feb;20(2):83–91. doi: 10.2337/diab.20.2.83. [DOI] [PubMed] [Google Scholar]
- Munro J. F., Seaton D. A., Duncan L. J. Treatment of refractory obesity with fenfluramine. Br Med J. 1966 Sep 10;2(5514):624–625. doi: 10.1136/bmj.2.5514.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nikkilä E. A., Taskinen M. R. The insulin secretion rate in obesity. Postgrad Med J. 1971 Jun;47(Suppl):412–417. [PubMed] [Google Scholar]
- Salans L. B., Knittle J. L., Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest. 1968 Jan;47(1):153–165. doi: 10.1172/JCI105705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stout R. W., Vallance-Owen J. Insulin and atheroma. Lancet. 1969 May 31;1(7605):1078–1080. doi: 10.1016/s0140-6736(69)91711-5. [DOI] [PubMed] [Google Scholar]
- Yalow R. S., Glick S. M., Roth J., Berson S. A. Plasma insulin and growth hormone levels in obesity and diabetes. Ann N Y Acad Sci. 1965 Oct 8;131(1):357–373. doi: 10.1111/j.1749-6632.1965.tb34803.x. [DOI] [PubMed] [Google Scholar]